Of inquiry directing the President to provide certain documents in the President's possession to the House of Representatives relating to communications by or among any of the Department of Health and Human Services, the Office of National Drug Control Policy, the White House, the Drug Enforcement Administration, and the Department of Justice related to the executive branch's recommendations for a long-term, consensus approach to reduce the supply and availability of illicitly manufactured fentanyl-related substances in the United States.
TQL analysis
Not yet gradedThis bill has no published Quiet Ledger grade yet.
Legislative structure
Criterion breakdown8 criteria · max 90
No grade to break down.Actions (6)
| Date | Time | Action |
|---|---|---|
| 2022-07-26 | — | Referred to the House Committee on Energy and Commerce. |
| 2022-07-26 | — | Introduced in House |
| 2022-07-26 | — | Introduced in House |
| 2022-09-29 | — | Placed on the House Calendar, Calendar No. 133. |
| 2022-09-29 | — | Reported by the Committee on Energy and Commerce. H. Rept. 117-527. |
| 2022-09-29 | — | Reported by the Committee on Energy and Commerce. H. Rept. 117-527. |
The Quiet Ledger grades legislation on its content. A bill grade is analysis of the bill — not a grade of its sponsor or of any member who voted on it.